Literature DB >> 25530216

ARF1 regulates adhesion of MDA-MB-231 invasive breast cancer cells through formation of focal adhesions.

Sabrina Schlienger1, Rodrigo Alain Migueles Ramirez1, Audrey Claing2.   

Abstract

Adhesion complex formation and disassembly is crucial for maintaining efficient cell movement. During migration, several proteins act in concert to promote remodeling of the actin cytoskeleton and we have previously shown that in highly invasive breast cancer cells, this process is regulated by small GTP-binding proteins of the ADP-ribosylation factor (ARF) family. These are overexpressed and highly activated in these cells. Here, we report that one mechanism by which ARF1 regulates migration is by controlling assembly of focal adhesions. In cells depleted of ARF1, paxillin is no longer colocalized with actin at focal adhesion sites. In addition, we demonstrate that this occurs through the ability of ARF1 to regulate the recruitment of key proteins such as paxillin, talin and FAK to ß1-integrin. Furthermore, we show that the interactions between paxillin and talin together and with FAK are significantly impaired in ARF1 knocked down cells. Our findings also indicate that ARF1 is essential for EGF-mediated phosphorylation of FAK and Src. Finally, we report that ARF1 can be found in complex with key focal adhesion proteins such as ß1-integrin, paxillin, talin and FAK. Together our findings uncover a new mechanism by which ARF1 regulates cell migration and provide this GTPase as a target for the development of new therapeutics in triple negative breast cancer.
Copyright © 2014 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  ADP-ribosylation factor-1; Breast cancer; Epidermal growth factor receptor; Focal adhesion; Focal adhesion kinase

Mesh:

Substances:

Year:  2014        PMID: 25530216     DOI: 10.1016/j.cellsig.2014.11.032

Source DB:  PubMed          Journal:  Cell Signal        ISSN: 0898-6568            Impact factor:   4.315


  19 in total

Review 1.  Golgi Complex: A Signaling Hub in Cancer.

Authors:  Daniela Spano; Antonino Colanzi
Journal:  Cells       Date:  2022-06-21       Impact factor: 7.666

2.  Cargo-specific recruitment in clathrin- and dynamin-independent endocytosis.

Authors:  Paulina Moreno-Layseca; Niklas Z Jäntti; Rashmi Godbole; Christian Sommer; Guillaume Jacquemet; Hussein Al-Akhrass; James R W Conway; Pauliina Kronqvist; Roosa E Kallionpää; Leticia Oliveira-Ferrer; Pasquale Cervero; Stefan Linder; Martin Aepfelbacher; Henrik Zauber; James Rae; Robert G Parton; Andrea Disanza; Giorgio Scita; Satyajit Mayor; Matthias Selbach; Stefan Veltel; Johanna Ivaska
Journal:  Nat Cell Biol       Date:  2021-10-06       Impact factor: 28.213

Review 3.  Endogenous and Exogenous Regulatory Signaling in the Secretory Pathway: Role of Golgi Signaling Molecules in Cancer.

Authors:  Simona Del Giudice; Valentina De Luca; Seyedehnegar Parizadeh; Domenico Russo; Alberto Luini; Rosaria Di Martino
Journal:  Front Cell Dev Biol       Date:  2022-03-23

Review 4.  Arf proteins in cancer cell migration.

Authors:  Cristina Casalou; Alexandra Faustino; Duarte C Barral
Journal:  Small GTPases       Date:  2016-09-02

5.  ADP-ribosylation factor 1 expression regulates epithelial-mesenchymal transition and predicts poor clinical outcome in triple-negative breast cancer.

Authors:  Sabrina Schlienger; Shirley Campbell; Sarah Pasquin; Louis Gaboury; Audrey Claing
Journal:  Oncotarget       Date:  2016-03-29

6.  Inhibition of growth and metastasis of triple-negative breast cancer targeted by Traditional Chinese Medicine Tubeimu in orthotopic mice models.

Authors:  Jingxiao Wang; Xinjie Yang; Haibo Han; Limin Wang; Weiqian Bao; Shanshan Wang; Robert M Hoffman; Meng Yang; Hui Qi; Chao An; Kaiwen Hu
Journal:  Chin J Cancer Res       Date:  2018-02       Impact factor: 5.087

7.  Conversion of nanoscale topographical information of cluster-assembled zirconia surfaces into mechanotransductive events promotes neuronal differentiation.

Authors:  Carsten Schulte; Simona Rodighiero; Martino Alfredo Cappelluti; Luca Puricelli; Elisa Maffioli; Francesca Borghi; Armando Negri; Elisa Sogne; Massimiliano Galluzzi; Claudio Piazzoni; Margherita Tamplenizza; Alessandro Podestà; Gabriella Tedeschi; Cristina Lenardi; Paolo Milani
Journal:  J Nanobiotechnology       Date:  2016-03-09       Impact factor: 10.435

8.  Recombinant protein of Haemonchus contortus small GTPase ADP-ribosylation factor 1 (HcARF1) modulate the cell mediated immune response in vitro.

Authors:  Javaid Ali Gadahi; Muhammad Ehsan; Shuai Wang; Zhenchao Zhang; Ruofeng Yan; Xiaokai Song; Lixin Xu; Xiangrui Li
Journal:  Oncotarget       Date:  2017-11-26

9.  Suppression of breast cancer metastasis through the inactivation of ADP-ribosylation factor 1.

Authors:  Xiayang Xie; Shou-Ching Tang; Yafei Cai; Wenhu Pi; Libin Deng; Guangyu Wu; Alain Chavanieu; Yong Teng
Journal:  Oncotarget       Date:  2016-09-06

10.  Functional disruption of the Golgi apparatus protein ARF1 sensitizes MDA-MB-231 breast cancer cells to the antitumor drugs Actinomycin D and Vinblastine through ERK and AKT signaling.

Authors:  Charlotte Luchsinger; Marcelo Aguilar; Patricia V Burgos; Pamela Ehrenfeld; Gonzalo A Mardones
Journal:  PLoS One       Date:  2018-04-03       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.